Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation

Publication date: May 2021Source: Journal of Orthopaedic Translation, Volume 28Author(s): Wen Guo, Haijun Li, Yan Lou, Yue Zhang, Jia Wang, Ming Qian, Haifeng Wei, Jianru Xiao, Youjia Xu

Source: Journal of Orthopaedic Translation - April 10, 2021 Category: Orthopaedics Source Type: research